Engineered Soluble ACE2 Protein and SARS-CoV-2 Variants of Concern (VOCs)
Coronaviruses
; 3(5) (no pagination), 2022.
Article
Dans Anglais
| EMBASE | ID: covidwho-2268502
Mots clés
covid-19, Engineered soluble ACE2 protein, epidemic illnesses, SARS-CoV-2, trimeric S protein, variants of concern, acute lung injury, adult respiratory distress syndrome, coronavirus disease 2019, cytokine storm, editorial, epidemic, exosome, fibrosis, human, ic50, in vitro study, in vivo study, innate immunity, pandemic, public health, pyroptosis, receptor binding, renin angiotensin aldosterone system, SARS-CoV-2 (lineage B.1), SARS-CoV-2 (variant B.1.1.7 UK/Alpha/mutant 69-70del), SARS-CoV-2 (variant B.1.351 RSA/Beta/mutant D614G), SARS-CoV-2 (variant B.1.617.2/Delta/India/mutant D614G; D950N), SARS-CoV-2 Gamma, Severe acute respiratory syndrome coronavirus 2, socioeconomics, trimerization, vaccination, vaccine development, variant of concern, vasodilatation, virus entry, virus shedding, virus spike, ADAM protein/ec [Endogenous Compound], angiotensin 2 receptor antagonist, angiotensin converting enzyme 2/ec [Endogenous Compound], angiotensin I/ec [Endogenous Compound], angiotensin II/ec [Endogenous Compound], angiotensin[1-7]/ec [Endogenous Compound], immunoglobulin G/ec [Endogenous Compound], monoclonal antibody/ec [Endogenous Compound], reactive oxygen metabolite, unclassified drug, vitronectin, angiotensin[1-9]/ec [Endogenous Compound]
Texte intégral:
Disponible
Collection:
Bases de données des oragnisations internationales
Base de données:
EMBASE
Les sujets:
Variantes
langue:
Anglais
Revue:
Coronaviruses
Année:
2022
Type de document:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS